Tumor Lysis Syndrome (TLS) following intrathecal chemotherapy in a child with acute myelogenous leukemia (AML)

Tumor Lysis Syndrome (TLS) is a well-known complication of induction therapy for hematologic malignancies. It is characterized by rapid breakdown of malignant white blood cells (WBCs) leading to metabolic derangements and serious morbidity if left untreated. Most commonly, TLS is triggered by system...

Descripción completa

Detalles Bibliográficos
Autor principal: Glasser, Chana L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678818/
https://www.ncbi.nlm.nih.gov/pubmed/29159035
http://dx.doi.org/10.1016/j.lrr.2017.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678818/
https://www.ncbi.nlm.nih.gov/pubmed/29159035
http://dx.doi.org/10.1016/j.lrr.2017.10.002

Ejemplares similares